Middle East And Africa Pen Needles Market Research Report – Segmented By Therapy, Type, Needle Length, Mode Of Purchase & By Country(KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Analysis on Size, Share, Trends, Growth, Forecast (2024 to 2029)
MEA Pen Needles Market Size (2024 to 2029)
The Middle East & Africa pen needles market size is expected to reach USD 0.54 billion by 2029 from USD 0.32 billion in 2024, growing at a CAGR of 10.77% for the next five years, 2024 to 2029.
Pen needles are used to deliver the medication (such as insulin or other injectable medications) combined with injection pens. A pen needle comprises a hollow needle attached to an injection pen. Pen needles are available with varied needle lengths and are majorly utilized by diabetes patients.
Growing annual health care expenditure, increasing public & private organizations' involvement in diabetes awareness programs, and rising demand for advanced insulin delivery devices drive the growth of the Middle East & Africa pen needles market. However, limited accessibility of pen needles and lack of health care infrastructure & outdated facilities are restraining the growth of the Middle East & Africa pen needles market.
This research report on the Middle East and Africa Pen Needles Market has been segmented and sub-segmented into the following categories
MEA Pen Needles Market Analysis By Therapy
- Insulin Therapy
- GLP-1 Therapy
- Growth Hormone Therapy
MEA Pen Needles Market Analysis By Type
- Standard Needle
- Safety Needle
MEA Pen Needles Market Analysis By Needle Length
- 4mm
- 6mm
- 8mm
- 10mm
- 12mm
MEA Pen Needles Market Analysis By Mode of Purchase
- Retail
- Non-Retail
MEA Pen Needles Market Analysis By Country
- KSA
- UAE
- Israel
- rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- rest of MEA
Companies leading the MEA Pen Needles Market profiled in this report are Becton Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), Owen Mumford, Ltd. (U.K.), B. Braun Melsungen (Germany), Artsana S.p.a. (Italy), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan) and others.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]